In addition, in TCGA patients with melanoma, reduced levels of ESRP1 (which encodes a master splicing regulator involved in EMT) were correlated with increased immune checkpoint expression (PD-L1 and CTLA4) and elevated tumor-associated immune cytolytic activity (Yao et al., 2016). This evidence concerns the gene CTLA4 and melanoma.